Atlas Trials

Evaluation of the Effect of Telmisartan (Micardis® 80 mg/ MicardisPlus® 80/12.5 mg) on Blood Pressure and Cardiovascular Risk Factor Index in High Risk Hypertensive Patients

Clinical trial NCT00904371 · COMPLETED

Trial details

NCT number
NCT00904371
Sponsor
Boehringer Ingelheim
Status
COMPLETED
Study type
OBSERVATIONAL
HypertensionCardiovascular Diseases
Start date
2009-12-01
Primary completion
2011-01-01
Enrollment
211

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.